The short answer
Glucomannan has not been shown to reduce miglitol’s absorption or effectiveness. A fiber study with glyburide cannot establish the same interaction for an intestinally acting drug.
What this answer covers
Oral konjac glucomannan; dose, viscosity and preparation differ. Miglitol tablets act locally in the intestine.
- Supplement or preparation
- Glucomannan
- Medication ingredient
- miglitol
The cited human experiment used glyburide
A small healthy-volunteer study found lower early glyburide concentrations when taken with konjac glucomannan. Glucose was also lower at one early time point, despite the lower drug concentration.
Miglitol has a different therapeutic mechanism
Glyburide acts after absorption. Miglitol acts at the intestinal surface, and its label says systemic absorption does not contribute to therapeutic effect. The glyburide result cannot demonstrate miglitol treatment failure.
Need and spacing are not established
The study does not show that miglitol creates a need for glucomannan or establish a protective interval. Changes in fiber intake may affect meals, but that does not identify an exact drug interaction.
Keep treatment and diet coordinated
Discuss the actual fiber product with the diabetes team and follow miglitol’s instructions to take it at the start of main meals. Review significant glucose or bowel-symptom changes rather than changing the drug schedule yourself.
Evidence and practical considerations
Timing & monitoring
No miglitol-specific glucomannan requirement or protective interval established.
- Exact scope
- Oral konjac glucomannan; dose, viscosity and preparation differ. Miglitol tablets act locally in the intestine. with Oral miglitol RxCUI30009 IN; local intestinal alpha-glucosidase action.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No arbitrary gap, systemic-exposure inference or exact unmeasured clinical-event rate.
Factors that may matter: Preparation; Meal timing; Dose; Other diabetes treatment.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral miglitol
Intestinal alpha-glucosidase inhibition; systemic absorption does not contribute to therapeutic effect. Alone should not cause hypoglycemia, but insulin/sulfonylurea co-use can increase their risk. Glucose rather than sucrose treats appropriate mild-to-moderate lows. Charcoal adsorbents and carbohydrate-splitting enzymes may reduce effect and should not be taken concomitantly.
How this applies: Exact oral miglitol and its local intestinal action distinguished from other diabetes medicines.
Class and named-product precautions do not establish each herb interaction, a quantified absorption change or arbitrary spacing interval.
Source 2: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Nine healthy volunteers.
Glucomannan blunted early glyburide concentrations; glucose was also lower at30minutes despite lower drug concentration.
How this applies: Exact miglitol applicability limited to identified drug, preparation and endpoint.
Nine healthy people and a different drug; early concentration differences do not establish miglitol absorption or efficacy loss.
Research assessment: · Open full citations ↗
Absorption & effectiveness
Different-drug early concentration findings do not establish miglitol absorption or efficacy loss.
- Exact scope
- Oral konjac glucomannan; dose, viscosity and preparation differ. Miglitol tablets act locally in the intestine. with Oral miglitol RxCUI30009 IN; local intestinal alpha-glucosidase action.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No arbitrary gap, systemic-exposure inference or exact unmeasured clinical-event rate.
Factors that may matter: Preparation; Meal timing; Dose; Other diabetes treatment.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral miglitol
Intestinal alpha-glucosidase inhibition; systemic absorption does not contribute to therapeutic effect. Alone should not cause hypoglycemia, but insulin/sulfonylurea co-use can increase their risk. Glucose rather than sucrose treats appropriate mild-to-moderate lows. Charcoal adsorbents and carbohydrate-splitting enzymes may reduce effect and should not be taken concomitantly.
How this applies: Exact oral miglitol and its local intestinal action distinguished from other diabetes medicines.
Class and named-product precautions do not establish each herb interaction, a quantified absorption change or arbitrary spacing interval.
Source 2: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Nine healthy volunteers.
Glucomannan blunted early glyburide concentrations; glucose was also lower at30minutes despite lower drug concentration.
How this applies: Exact miglitol applicability limited to identified drug, preparation and endpoint.
Nine healthy people and a different drug; early concentration differences do not establish miglitol absorption or efficacy loss.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact miglitol article distinguishing local efficacy, systemic absorption and product-specific timing. | |
| Research summary published |
Article revision: dcf0490a30ce4cd2
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.